VGW.V - Valens GroWorks Corp.

TSXV - TSXV Delayed Price. Currency in CAD
3.2600
-0.1200 (-3.55%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.3800
Open3.3800
Bid3.2500 x N/A
Ask3.2900 x N/A
Day's Range3.2600 - 3.3900
52 Week Range2.7000 - 4.6900
Volume261,062
Avg. Volume454,860
Market Cap401.632M
Beta (3Y Monthly)6.23
PE Ratio (TTM)N/A
EPS (TTM)-0.1810
Earnings DateOct 15, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.85
  • Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
    CNW Group

    Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019

    Net income of $5.9 million (or $0.05 per share basic and diluted) in the third quarter, compared to a net loss of $10.5 million (or a loss of $0.10 per share basic and diluted) in the second quarter of 2019. "We are extremely pleased with the roll-out of our business plan and the continued scale up in the Company's extraction operations which have allowed us to continue our aggressive quarter over quarter growth in volumes, revenue, adjusted EBITDA and net income." said Tyler Robson , CEO of Valens. "The Company's performance in the third quarter clearly demonstrates our industry leading technical capabilities, the quality of our products and the earnings power of our platform.

  • Newsfile

    Benzinga Announces: Valens GroWorks Corp. Presenting at the Cannabis Capital Conference in Chicago

    Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October 22-23 before an audience of well-vetted public and private companies, and an audience of fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market. Investment opportunities abound. For more information and/or to register for the conference please visit: ...

  • Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019
    CNW Group

    Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019

    Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019

  • Cannabis stocks rise for third straight day as vaping fears appear to ease
    MarketWatch

    Cannabis stocks rise for third straight day as vaping fears appear to ease

    Cannabis stocks rise for a third straight day Friday, buoyed by reports that vape sales are rebounding after being hit by the outbreak of a serious lung disease that experts say is directly tied to vaping.

  • Valens Announces Results of Annual General and Special Meeting of Shareholders
    CNW Group

    Valens Announces Results of Annual General and Special Meeting of Shareholders

    Valens Announces Results of Annual General and Special Meeting of Shareholders

  • Market Exclusive

    Cannabis Stock News Daily Roundup September 24

    Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) (Frankfurt: 0QV) has extended the expiry date of 27,235,027 share purchase warrants issued on October 1, 2018, for one year in conjunction with the company's non-brokered private placement of $25 million. Each warrant entitles the holder to purchase one subordinate voting share of Dixie at an exercise price of $1.32 per share. […]The post Cannabis Stock News Daily Roundup September 24 appeared first on Market Exclusive.

  • Market Exclusive

    Valens Gets Approval to Sell Cannabis Oil Directly to Distributors

    Valens GroWorks (TSXV: VGW) (OTCQX: VGWCF) announced that it has received an amended license from Health Canada related to the sale of its oil products as well as reported an update on the progress to build a white label manufacturing facility. New License a Significant Milestone The new license allows Valens to manufacture and supply oil […]The post Valens Gets Approval to Sell Cannabis Oil Directly to Distributors appeared first on Market Exclusive.

  • Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update
    CNW Group

    Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update

    Under the new license, Valens is now authorized to manufacture and supply oil products directly to provincial distributors and other authorized Canadian retail supply channels. Valens will immediately start leveraging this amended license to expand services provided to its white label manufacturing partners, delivering retail ready products including tinctures and gel caps.  The Company plans to further expand its retail ready product offerings to include vaporizer cartridges, beverages, topicals and other desired products as permitted by Health Canada.

  • Market Exclusive

    Valens Picks Iconic Brewing to Sell Cannabis-Infused Beverages

    Valens GroWorks (TSXV: VGW) (OTCQX: VGWCF) has entered into a five-year, white-label cannabis-infused beverage contract with the cannabis division of Iconic Brewing. Under the white label agreement, Valens will provide high-quality extracts, formulation services, and SōRSE emulsion IP for its cannabis-infused beverages. Whereas, Iconic will brand and market the final product across Canada. Under the terms of the […]The post Valens Picks Iconic Brewing to Sell Cannabis-Infused Beverages appeared first on Market Exclusive.

  • Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products
    PR Newswire

    Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products

    KELOWNA, BC , Sept. 16, 2019 /PRNewswire/ -  Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF)  (the " Company " or " Valens "), a vertically integrated provider of industry leading extraction ...

  • Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company's Cannabis Division
    CNW Group

    Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company's Cannabis Division

    Valens is excited to announce a white label agreement with Iconic to provide high quality extracts, formulation services, and SōRSE™ emulsion IP for its cannabis infused beverages. Iconic will brand and market the final product across Canada . "We are thrilled to partner with Iconic Brewing, one of the fastest growing alcohol beverage companies in eastern Canada , to help create their new line of cannabis-infused beverages," said Tyler Robson , CEO of Valens.

  • Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th
    CNW Group

    Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th

    The Company expects to report that it has extracted over 26,000 kilograms of cannabis and hemp biomass in the third quarter of 2019. This represents a significant ramp in extraction volumes compared with the 8,547 kilograms of dried cannabis and hemp biomass it processed in the second quarter of 2019, driven by the build out of the Company's ethanol extraction capabilities and increasing volumes from our new and existing customers.

  • Valens Begins Trading on the OTCQX Best Market in the U.S.
    PR Newswire

    Valens Begins Trading on the OTCQX Best Market in the U.S.

    KELOWNA, BC , Aug. 19, 2019 /PRNewswire/ -  Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF)  (the " Company " or " Valens "), a vertically integrated provider of industry leading extraction ...

  • Valens Added to NYSE-Listed Cannabis ETF
    CNW Group

    Valens Added to NYSE-Listed Cannabis ETF

    Valens Added to NYSE-Listed Cannabis ETF

  • Valens Gears Up For Geographic Expansion With New Offices In Toronto
    PR Newswire

    Valens Gears Up For Geographic Expansion With New Offices In Toronto

    Opening offices in downtown Toronto is a key next step in Valens' evolution as it looks to leverage its state of the art operations, technical expertise and advanced product portfolio in new, high value markets, globally. A Toronto office improves the Company's ability to realize on a number of international opportunities, increases its ability to attract and retain top talent, coordinate global operations, manage international customer relationships and expand access to the institutional investment community.

  • Market Exclusive

    Cannabis Stock News Daily Roundup July 16

    MYM Nutraceuticals (CSE: MYM) (OTCBB: MYMMF) reported that planting is now complete for the 2019 growing season at the CBD-rich hemp project situated on 120-acres in Nye County, Nev. MYM has entered into a production agreement with Elite Ventures and invested $500,000 to grow one pivot of 120-acres of CBD-rich hemp in Nevada. Elite will […]The post Cannabis Stock News Daily Roundup July 16 appeared first on Market Exclusive.

  • Valens Reports Record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019
    CNW Group

    Valens Reports Record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019

    Gross profit increased to $5.1 million , or 58.0% of revenue, for the second quarter of 2019 compared to $0.9 million or 38.3% of revenue in the first quarter. Adjusted EBITDA(1) of $2.0 million in the second quarter, or 23.0% of revenue. Increased annual extraction capacity significantly to 425,000 KG of dried cannabis and hemp biomass in the second quarter of 2019 to meet increasing customer demand with plans to further increase capacity to over 1,000,000 KG per year with the buildout of the adjacent facility in Kelowna, BC anticipated to be completed in H1 2020.